BLT 0.00% 2.6¢ benitec biopharma limited

Chartist Requiried, page-25

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Let's make up the rumour from the posts here.

    Word is, Benitec is about to merge with 4D Molecular Therapeutics, with a view to fast-tracking AMD. The new enity will be called Vespers Biopharma and will seek to raise $50M in a secondary public offering managed by RA Capital.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.